Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

CompletedOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
HIV Infections
Interventions
BEHAVIORAL

NO BI Drug administered

Trial Locations (36)

14604

Boehringer Ingelheim Investigational Site, Rochester

21201

Boehringer Ingelheim Investigational Site, Baltimore

23666

Boehringer Ingelheim Investigational Site, Hampton

28078

Boehringer Ingelheim Investigational Site, Huntersville

28209

Boehringer Ingelheim Investigational Site, Charlotte

32117

Boehringer Ingelheim Investigational Site, Daytona Beach

32504

Boehringer Ingelheim Investigational Site, Pensacola

33133

Boehringer Ingelheim Investigational Site, Miami

33137

Boehringer Ingelheim Investigational Site, Miami

33308

Boehringer Ingelheim Investigational Site, Fort Lauderdale

33316

Boehringer Ingelheim Investigational Site, Fort Lauderdale

33408

Boehringer Ingelheim Investigational Site, North Palm Beach

44304

Boehringer Ingelheim Investigational Site, Akron

48072

Boehringer Ingelheim Investigational Site, Berkley

60613

Boehringer Ingelheim Investigational Site, Chicago

63139

Boehringer Ingelheim Investigational Site, St Louis

70121

Boehringer Ingelheim Investigational Site, New Orleans

75246

Boehringer Ingelheim Investigational Site, Dallas

76104

Boehringer Ingelheim Investigational Site, Fort Worth

77004

Boehringer Ingelheim Investigational Site, Houston

90028

Boehringer Ingelheim Investigational Site, Los Angeles

90069

Boehringer Ingelheim Investigational Site, Los Angeles

90211

Boehringer Ingelheim Investigational Site, Beverly Hills

92663

Boehringer Ingelheim Investigational Site, Newport Beach

92708

Boehringer Ingelheim Investigational Site, Fountain Valley

93301

Boehringer Ingelheim Investigational Site, Bakersfield

94609

Boehringer Ingelheim Investigational Site, Oakland

97209

Boehringer Ingelheim Investigational Site, Portland

94305-5107

Boehringer Ingelheim Investigational Site, Stanford

01107

Boehringer Ingelheim Investigational Site, Springfield

08103

Boehringer Ingelheim Investigational Site, Camden

07102

Boehringer Ingelheim Investigational Site, Newark

07103

Boehringer Ingelheim Investigational Site, Newark

08043

Boehringer Ingelheim Investigational Site, Voorhees Township

00717-1563

Boehringer Ingelheim Investigational Site, Ponce

00731

Boehringer Ingelheim Investigational Site, Ponce

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY